Apr 08, 2015 12:00 AM
Garvan is very pleased to announce that Professor Mark Febbraio has joined us as Head of the Diabetes and Metabolism Division
Apr 07, 2015 04:00 AM
Executive Director of Garvan, Professor John Mattick AO FAA FRCPA, and Endocrinologist Professor John Eisman AO, were recently inducted as Fellows of the newly-created Academy of Health and Medical Sciences.
MEDIA RELEASE: Apr 01, 2015 03:00 AM
Garvan scientists have discovered a new population of ‘memory’ immune cells, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will enable the development of more targeted and effective vaccines.
MEDIA RELEASE: Mar 30, 2015 01:00 AM
Genes that help build strong bones in Europeans or Australians may have a very different effect in people from Southeast Asia.
MEDIA RELEASE: Mar 27, 2015 09:00 PM
Garvan researchers have found that so-called ‘triple-negative breast cancers’ are two distinct diseases that likely originate from different cell types. They have also found a gene that drives the aggressive disease, and hope to find a way to ‘switch it off’.
MEDIA RELEASE: Mar 23, 2015 12:05 AM
Garvan scientists receive support from The Michael J. Fox Foundation for Parkinson’s Research to speed progress in developing a novel therapy for Parkinson’s disease.
MEDIA RELEASE: Mar 10, 2015 03:00 AM
A new gene sequencing technology known as ‘Capture Sequencing’ (CaptureSeq) allows us to explore the human genome at a much higher resolution than ever before, with revolutionary implications for research and cancer diagnosis.
MEDIA RELEASE: Feb 26, 2015 05:00 AM
Scientists from Australia and the UK have done the most in-depth analysis yet of 100 pancreatic cancer genomes and highlighted 4 subtypes that may help guide future patient treatment. The study is published in Nature today.
Feb 25, 2015 02:41 PM
Congratulations to Ksenia Skvortsova, Amanda Khoury and Qian Du.
Feb 19, 2015 12:00 AM
Congratulations to PhD student Saul Bert.
Feb 19, 2015 12:00 AM
Congratulations to Garvan PhD candidates Deborah Burnett and Bethany Pillay.
Feb 18, 2015 12:00 AM
Congratulations to Garvan Cancer PhD student Mun Ngah Hui.
MEDIA RELEASE: Feb 16, 2015 05:00 AM
Associate Professor Stuart Tangye has been awarded a prestigious scholarship by the Australian American Fulbright Commission, an educational and cultural exchange program underwritten by the Australian and U.S. Governments.
MEDIA RELEASE: Feb 05, 2015 05:00 AM
In today’s issue of Nature, a worldwide group of antibody experts appeal for a standardised approach to the creation and use of antibodies in research and therapeutics.
MEDIA RELEASE: Feb 02, 2015 09:00 PM
Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.
MEDIA RELEASE: Feb 01, 2015 09:00 AM
The Garvan Institute of Medical Research is delighted to announce that distinguished immunologist and molecular geneticist, Professor Chris Goodnow FAA FRS, has now taken up his position as the Institute’s Deputy Director. He has also assumed The Bill and Patricia Ritchie Foundation Chair.
MEDIA RELEASE: Jan 30, 2015 06:00 AM
Life scientists now have access to a publicly available web resource that streamlines and simplifies the process of gleaning insight from 3D protein structures. Aquaria, as it's known, is fast, easy-to-use and contains twice as many models as all other similar resources combined.
MEDIA RELEASE: Jan 22, 2015 10:00 AM
The American Association of Immunologists (AAI) has selected Professor Jonathan Sprent FAA FRS, from Sydney’s Garvan Institute of Medical Research, to be the 2015 recipient of the AAI Lifetime Achievement Award.
MEDIA RELEASE: Jan 15, 2015 11:00 AM
The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies. Solvanix has secured a $2 million commitment from Australia’s Medical Research Commercialisation Fund (MRCF), and will be based at Garvan.